ROLE OF FARNESOID X RECEPTOR AGONISTS IN THE IN VIVO AND IN VITRO EXPRESSION OF APOLIPOPROTEIN(a)

被引：0
|
作者：
Chennamsetty, I. [1 ]
Kostner, G. [1 ]
机构：
[1] Med Univ Graz, Graz, Austria
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2010年 / 11卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(10)70277-4
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P210
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [41] Conformationally constrained farnesoid X receptor (FXR) agonists: Alternative replacements of the stilbene
    Akwabi-Ameyaw, Adwoa
    Caravella, Justin A.
    Chen, Lihong
    Creech, Katrina L.
    Deaton, David N.
    Madauss, Kevin P.
    Marr, Harry B.
    Miller, Aaron B.
    Navas, Frank, III
    Parks, Derek J.
    Spearing, Paul K.
    Todd, Dan
    Williams, Shawn P.
    Wisely, Bruce
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (20) : 6154 - 6160
  • [42] Novel heterocyclic scaffolds of GW4064 as farnesoid X receptor agonists
    Smalley, Terrence L., Jr.
    Boggs, Sharon
    Caravella, Justin A.
    Chen, Lihong
    Creech, Katrina L.
    Deaton, David N.
    Kaldor, Istvan
    Parks, Derek J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (02) : 280 - 284
  • [43] Design, synthesis and biological evaluations of novel farnesoid X receptor (FXR) agonists
    Zhu, Yuanju
    Zhang, Jay
    Min, Feng
    Yang, Xinying
    Li, Li
    Zhang, Yan
    Hou, Xuben
    Fang, Hao
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 76
  • [44] Therapeutic potential of farnesoid X receptor agonists for modulating inflammation and periodontal regeneration
    Huang, Jie
    Zhang, Huang
    Fan, Xusheng
    Wang, Yongwu
    CLINICAL ORAL INVESTIGATIONS, 2024, 29 (01)
  • [45] Identifying farnesoid X receptor agonists by naive Bayesian and recursive partitioning approaches
    Ding, Qianzhi
    Li, Chanjuan
    Wang, Ling
    Li, Yali
    Zhou, Huihao
    Gu, Qiong
    Xu, Jun
    MEDCHEMCOMM, 2015, 6 (07) : 1393 - 1403
  • [46] Medicinal chemistry of farnesoid X receptor ligands: from agonists and antagonists to modulators
    Merk, Daniel
    Steinhilber, Dieter
    Schubert-Zsilavecz, Manfred
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (08) : 1015 - 1036
  • [47] EDP-305, a highly selective and potent farnesoid X receptor agonist, favorably regulates the expression of key fibrogenic genes in vitro and in vivo
    Li, Y.
    Shang, J.
    Chau, M.
    Roqueta-Riverta, M.
    Garlick, K.
    An, P.
    Vaid, K.
    Popov, Y.
    Or, Y. S.
    Jiang, L.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S398 - S398
  • [48] Activation of estrogen receptor α increases and estrogen receptor β decreases apolipoprotein E expression in hippocampus in vitro and in vivo
    Wang, Jun Ming
    Irwin, Ronald W.
    Brinton, Roberta Diaz
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (45) : 16983 - 16988
  • [49] Inhibition of leydig tumor growth by farnesoid X receptor activation: The in vitro and in vivo basis for a novel therapeutic strategy
    Catalano, Stefania
    Panza, Salvatore
    Malivindi, Rocco
    Giordano, Cinzia
    Barone, Ines
    Bossi, Gianluca
    Lanzino, Marilena
    Sirianni, Rosa
    Mauro, Loredana
    Sisci, Diego
    Bonofiglio, Daniela
    Ando, Sebastiano
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (10) : 2237 - 2247
  • [50] Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo
    Wang, Yan-Dong
    Yang, Fan
    Chen, Wei-Dong
    Huang, Xiongfei
    Lai, Lily
    Forman, Barry M.
    Huang, Wendong
    MOLECULAR ENDOCRINOLOGY, 2008, 22 (07) : 1622 - 1632
12345